Human Fetal Cell Therapy in Huntington's Disease: A Randomized, Multicenter, Phase II Trial. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/mds.28201
PubMed Identifier: 32666599
Publication URI: http://europepmc.org/abstract/MED/32666599
Type: Journal Article/Review
Volume: 35
Parent Publication: Movement disorders : official journal of the Movement Disorder Society
Issue: 8
ISSN: 0885-3185